Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06679101 |
| Title | A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM) (DREAMM-10) |
| Acronym | DREAMM-10 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | ARG |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | RECRUITING | Ciudad Autonoma de Buenos Aire | 1414 | Argentina | Details | |
| GSK Investigational Site | RECRUITING | Hwasun | 519-763 | Korea, Republic of | Details | |
| GSK Investigational Site | RECRUITING | Jeonju | 561-712 | Korea, Republic of | Details | |
| GSK Investigational Site | RECRUITING | Ulsan | 44033 | Korea, Republic of | Details |